Titan Biotech bonus issue: 1:4 ratio, credit by 03 November 2026
Board recommends 1:4 bonus shares of Rs. 2 each, with record date to be announced; final dividend record date is 22 September 2026.
Key takeaways
- Bonus ratio set at 1:4 i.e. 1 Equity Share for every 4 existing Equity Shares held as on a record date.
- Total 1,03,29,625 bonus shares of Rs. 2 each proposed, subject to shareholders’ approval.
- Rs. 2,06,59,250 from reserves is required for implementing the bonus issue.
- Record date for bonus eligibility will be informed in due course of time.
- Final dividend of Rs. 0.50/- per shares has record date on Tuesday, September 22, 2026.
Key terms
- Action
- Bonus issue
- Terms
- 1:4
- Record date
- 23 October 2026
- Bonus shares to be credited/dispatched on or before November 03, 2026, subject to approvals.
- Dividend and AGM record date fixed as Tuesday, September 22, 2026.
Titan Biotech Limited’s board has recommended a bonus issue of equity shares and confirmed the record date for its previously announced final dividend, according to the outcome of the board meeting held on September 03, 2026.
Key terms
- Type of action (bonus): Issue of bonus equity shares
- Bonus ratio: 1:4 i.e. 1 (One) Equity Shares for every 4 (Four) existing Equity Shares held as on a record date (Annexure-A, item v.)
- Face value: Rs. 2/- each for both existing and new fully paid-up equity shares (board's outcome letter, item A)
- Total number of bonus shares proposed: 1,03,29,625 Shares (Annexure-A, item iii.)
- Source of bonus: Securities Premium account and/or retained earnings and/or free reserves and/or any other permitted reserves/surplus of the Company available as at March 31, 2026 (Annexure-A, item iv.)
- Free reserves/share premium required for bonus: Rs. 2,06,59,250 (Annexure-A, item vii.)
- Free reserves/share premium available for capitalization: 162.58 cr as on 31st March, 2026 (Annexure-A, item viii.)
- Pre-bonus authorised share capital: 5,00,00,000 equity shares of Rs. 2 each, total Rs. 10,00,00,000 (Annexure-A, item vi.)
- Post-bonus authorised share capital (after proposed increase): 5,20,00,000 equity shares of Rs. 2 each, total Rs. 10,40,00,000 (Annexure-A, item vi.)
- Pre-bonus paid-up and subscribed capital: 4,13,18,500 shares of Rs. 2, total Rs. 8,26,37,000 (Annexure-A, item vi.)
- Post-bonus paid-up and subscribed capital: 5,16,48,125 shares of Rs. 2, total Rs. 10,32,96,250 (Annexure-A, item vi.)
- Estimated date for credit/dispatch of bonus shares: within 2 months from the date of Board's approval i.e. on or before November 03, 2026 subject to necessary approvals (Annexure-A, item x.)
- Dividend amount: final dividend of Rs. 0.50/- (Rupees Fifty Paisa Only) per shares (board's outcome letter, item F)
- Dividend record date / AGM record date: Tuesday, September 22, 2026 (board's outcome letter, item F)
What has been approved and what is pending
According to the board's outcome letter dated September 03, 2026, the Board of Directors has considered and approved the issuance of Bonus shares to the Equity shareholders of the Company in the ratio of 1:4 i.e. 1(one) new fully paid-up bonus equity shares of Rs. 2/- each for every 4 (Four) existing fully paid-up equity shares of Rs. 2/- each held by the members as on the record date, subject to the members approval in forthcoming Annual General Meeting of the company.
The company states that the Record Date for the purpose of determining the equity shareholders of the Company eligible for bonus equity shares of the Company will be informed in due course of time (board's outcome letter, item A). As of this filing, the bonus issue record date has not been announced.
To facilitate the bonus issue, the board has also considered and approved the Increase in the Authorised Share Capital of the Company from Rs. 10,00,00,000/- (Rupees Ten Crore) divided into 5,00,00,000 (Five Crore) Equity Shares of Rs. 2/- (Rupees Two) each to Rs. 10,40,00,000/- (Rupees Ten Crore and Forty Lakhs) divided into 5,20,00,000 (Five Crore and Twenty Lakhs) Equity Shares of Rs. 2/- (Rupees Two) each, subject to the approval of shareholders in the forthcoming Annual General Meeting and such other approvals as may be required (board's outcome letter, item B and Annexure-B).
Eligibility for the bonus shares
Shareholders who hold fully paid-up equity shares of Rs. 2/- each as on the record date for the bonus issue will be entitled to receive 1 (One) Equity Shares for every 4 (Four) existing Equity Shares held. The company has clarified that this record date will be informed in due course of time.
Dividend record date and AGM schedule
Separately from the bonus issue, the board has reiterated that it had earlier recommended a final dividend of Rs. 0.50/- (Rupees Fifty Paisa Only) per shares. The record date for the purpose of the Annual General Meeting and payment of dividend is Tuesday, September 22, 2026 (board's outcome letter, item F).
The Thirty-Fourth (34th) Annual General Meeting ("AGM") of the company has been scheduled for Tuesday, September 29, 2026, through Video Conferencing ("VC")/Other AudioVisual Means ("OAVM") (board's outcome letter, item D). The company has also fixed Tuesday, September 22, 2026 as the "Cut-off Date" for determining members eligible to vote on the AGM resolutions (board's outcome letter, item E).
The company states in the board's outcome letter that the Bonus shares will be credited/dispatched within 2 months from the date of Board's approval i.e. on or before November 03, 2026 subject to necessary approvals.
Update (09 October 2026): the company has since fixed the record date for this action as 2026-10-23.
Track Titan Biotech Ltd
Cruxal reads every Titan Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
